Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
In recent years, several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease (PD) and Huntington's disease (HD). Despite distinct clinical and pathological features, these two neurodegenerative diseases share...
Main Authors: | Sandra Franco-Iborra, Miquel Vila, Celine Perier |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2018.00342/full |
Similar Items
-
Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases
by: Ju Gao, et al.
Published: (2017-04-01) -
Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
by: Jannik Prasuhn, et al.
Published: (2021-01-01) -
Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA
by: Olga Buneeva, et al.
Published: (2020-12-01) -
Characterizing the Huntington's disease, Parkinson's disease, and pan-neurodegenerative gene expression signature with RNA sequencing
by: Labadorf, Adam
Published: (2016) -
Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases
by: Isaac G Onyango, et al.
Published: (2021-01-01)